229 related articles for article (PubMed ID: 29951539)
1. Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan.
Kawase T; Okuda K
Biomed Res Int; 2018; 2018():6389157. PubMed ID: 29951539
[TBL] [Abstract][Full Text] [Related]
2. Platelet-Rich Plasma Powder: A New Preparation Method for the Standardization of Growth Factor Concentrations.
Kieb M; Sander F; Prinz C; Adam S; Mau-Möller A; Bader R; Peters K; Tischer T
Am J Sports Med; 2017 Mar; 45(4):954-960. PubMed ID: 27903591
[TBL] [Abstract][Full Text] [Related]
3. The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future.
Kawase T; Mubarak S; Mourão CF
Bioengineering (Basel); 2020 Jul; 7(3):. PubMed ID: 32751638
[TBL] [Abstract][Full Text] [Related]
4. Regulatory Frameworks for Gene and Cell Therapies in Japan.
Maeda D; Yamaguchi T; Ishizuka T; Hirata M; Takekita K; Sato D
Adv Exp Med Biol; 2015; 871():147-62. PubMed ID: 26374217
[TBL] [Abstract][Full Text] [Related]
5. Regulatory perspectives of Japan.
Kusakabe T
Biologicals; 2015 Sep; 43(5):422-4. PubMed ID: 26028474
[TBL] [Abstract][Full Text] [Related]
6. Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances.
Kawase T
Odontology; 2015 May; 103(2):126-35. PubMed ID: 26040505
[TBL] [Abstract][Full Text] [Related]
7. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
8. Autologous Platelet-Rich Plasma Efficacy in the Field of Regenerative Medicine: Product and Quality Control.
Popescu MN; Iliescu MG; Beiu C; Popa LG; Mihai MM; Berteanu M; Ionescu AM
Biomed Res Int; 2021; 2021():4672959. PubMed ID: 34368346
[TBL] [Abstract][Full Text] [Related]
9. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors.
Amable PR; Carias RB; Teixeira MV; da Cruz Pacheco I; Corrêa do Amaral RJ; Granjeiro JM; Borojevic R
Stem Cell Res Ther; 2013 Jun; 4(3):67. PubMed ID: 23759113
[TBL] [Abstract][Full Text] [Related]
10. Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications.
Giannotti L; Di Chiara Stanca B; Spedicato F; Nitti P; Damiano F; Demitri C; Calabriso N; Carluccio MA; Palermo A; Siculella L; Stanca E
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761809
[TBL] [Abstract][Full Text] [Related]
11. Blood Plasma Derivatives for Tissue Engineering and Regenerative Medicine Therapies.
Santos SCNDS; Sigurjonsson ÓE; Custódio CA; Mano JFCDL
Tissue Eng Part B Rev; 2018 Dec; 24(6):454-462. PubMed ID: 29737237
[TBL] [Abstract][Full Text] [Related]
12. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
Singh RP; Marwaha N; Malhotra P; Dash S
Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
[TBL] [Abstract][Full Text] [Related]
13. Autologous platelet concentrates in maxillofacial regenerative therapy.
Chou TM; Chang HP; Wang JC
Kaohsiung J Med Sci; 2020 May; 36(5):305-310. PubMed ID: 32052598
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of platelet concentrates prepared from whole blood donations with collection times between 12 and 15 min: The BEST Collaborative study.
de Korte D; Bontekoe IJ; Fitzpatrick Á; Marks D; Wood B; Gravemann U; Bohoněk M; Kutner JM;
Vox Sang; 2022 May; 117(5):671-677. PubMed ID: 35023205
[TBL] [Abstract][Full Text] [Related]
15. Platelet-Derived Products in Veterinary Medicine: A New Trend or an Effective Therapy?
Soares CS; Babo PS; Reis RL; Carvalho PP; Gomes ME
Trends Biotechnol; 2021 Mar; 39(3):225-243. PubMed ID: 32868100
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates.
Hoareau GL; Jandrey KE; Burges J; Bremer D; Tablin F
Vet Clin Pathol; 2014 Dec; 43(4):513-8. PubMed ID: 25267468
[TBL] [Abstract][Full Text] [Related]
17. Advances in Platelet Rich Plasma-Derived Extracellular Vesicles for Regenerative Medicine: A Systematic-Narrative Review.
Anitua E; Troya M; Falcon-Pérez JM; López-Sarrio S; González E; Alkhraisat MH
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685849
[TBL] [Abstract][Full Text] [Related]
18. Current status of platelet-rich plasma therapy under the act on the safety of regenerative medicine in Japan.
Arita A; Tobita M
Regen Ther; 2023 Jun; 23():37-43. PubMed ID: 37063096
[TBL] [Abstract][Full Text] [Related]
19. Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Navani A; Manchikanti L; Albers SL; Latchaw RE; Sanapati J; Kaye AD; Atluri S; Jordan S; Gupta A; Cedeno D; Vallejo A; Fellows B; Knezevic NN; Pappolla M; Diwan S; Trescot AM; Soin A; Kaye AM; Aydin SM; Calodney AK; Candido KD; Bakshi S; Benyamin RM; Vallejo R; Watanabe A; Beall D; Stitik TP; Foye PM; Helander EM; Hirsch JA
Pain Physician; 2019 Jan; 22(1S):S1-S74. PubMed ID: 30717500
[TBL] [Abstract][Full Text] [Related]
20. Storage of single donor platelet concentrates: paired comparison of storage as single or double concentrates.
Glaser A; Friedlein H; Zingsem J; Zimmermann R; Weisbach V; Ruf A; Eckstein R
J Clin Apher; 2001; 16(3):148-54. PubMed ID: 11746543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
